458 related articles for article (PubMed ID: 18253104)
1. Metastasis: a therapeutic target for cancer.
Steeg PS; Theodorescu D
Nat Clin Pract Oncol; 2008 Apr; 5(4):206-19. PubMed ID: 18253104
[TBL] [Abstract][Full Text] [Related]
2. The challenge of targeting metastasis.
Fidler IJ; Kripke ML
Cancer Metastasis Rev; 2015 Dec; 34(4):635-41. PubMed ID: 26328524
[TBL] [Abstract][Full Text] [Related]
3. Novel approaches with targeted therapies in bladder cancer. Therapy of bladder cancer by blockade of the epidermal growth factor receptor family.
Bellmunt J; Hussain M; Dinney CP
Crit Rev Oncol Hematol; 2003 Jun; 46 Suppl():S85-104. PubMed ID: 12850530
[TBL] [Abstract][Full Text] [Related]
4. Blockade of neoangiogenesis, a new and promising technique to control the growth of malignant tumors and their metastases.
Grimm D; Bauer J; Schoenberger J
Curr Vasc Pharmacol; 2009 Jul; 7(3):347-57. PubMed ID: 19601859
[TBL] [Abstract][Full Text] [Related]
5. Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis.
Pàez-Ribes M; Allen E; Hudock J; Takeda T; Okuyama H; Viñals F; Inoue M; Bergers G; Hanahan D; Casanovas O
Cancer Cell; 2009 Mar; 15(3):220-31. PubMed ID: 19249680
[TBL] [Abstract][Full Text] [Related]
6. Current and future approaches for the therapeutic targeting of metastasis (review).
Germanov E; Berman JN; Guernsey DL
Int J Mol Med; 2006 Dec; 18(6):1025-36. PubMed ID: 17089005
[TBL] [Abstract][Full Text] [Related]
7. Tumor angiogenesis and therapy.
Cao Y
Biomed Pharmacother; 2005 Oct; 59 Suppl 2():S340-3. PubMed ID: 16507405
[TBL] [Abstract][Full Text] [Related]
8. The Applications of Targeting Anti-Cancer Agents in Cancer Therapeutics.
Sun GC; Yang X; Yu Y; Zhao DW
Anticancer Agents Med Chem; 2015; 15(7):869-80. PubMed ID: 25783965
[TBL] [Abstract][Full Text] [Related]
9. Differential drug class-specific metastatic effects following treatment with a panel of angiogenesis inhibitors.
Chung AS; Kowanetz M; Wu X; Zhuang G; Ngu H; Finkle D; Komuves L; Peale F; Ferrara N
J Pathol; 2012 Aug; 227(4):404-16. PubMed ID: 22611017
[TBL] [Abstract][Full Text] [Related]
10. Smart drugs: tyrosine kinase inhibitors in cancer therapy.
Shawver LK; Slamon D; Ullrich A
Cancer Cell; 2002 Mar; 1(2):117-23. PubMed ID: 12086869
[TBL] [Abstract][Full Text] [Related]
11. Anti-VEGF strategies - from antibodies to tyrosine kinase inhibitors: background and clinical development in human cancer.
Korpanty G; Smyth E
Curr Pharm Des; 2012; 18(19):2680-701. PubMed ID: 22390756
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic targets of multiple angiogenic factors for the treatment of cancer and metastasis.
Cao Y; Liu Q
Adv Cancer Res; 2007; 97():203-24. PubMed ID: 17419947
[TBL] [Abstract][Full Text] [Related]
13. Beyond Angiogenesis: Exploiting Angiocrine Factors to Restrict Tumor Progression and Metastasis.
Singhal M; Augustin HG
Cancer Res; 2020 Feb; 80(4):659-662. PubMed ID: 31831463
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor (VEGF) as a target of bevacizumab in cancer: from the biology to the clinic.
Ranieri G; Patruno R; Ruggieri E; Montemurro S; Valerio P; Ribatti D
Curr Med Chem; 2006; 13(16):1845-57. PubMed ID: 16842197
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor receptors: expression and function in solid tumors.
Wey JS; Stoeltzing O; Ellis LM
Clin Adv Hematol Oncol; 2004 Jan; 2(1):37-45. PubMed ID: 16163158
[TBL] [Abstract][Full Text] [Related]
16. The impact of gefitinib on epidermal growth factor receptor signaling pathways in cancer.
Averbuch SD
Clin Lung Cancer; 2003 Sep; 5 Suppl 1():S5-S10. PubMed ID: 14641988
[TBL] [Abstract][Full Text] [Related]
17. Endothelium and cancer metastasis: Perspectives for antimetastatic therapy.
Blazejczyk A; Papiernik D; Porshneva K; Sadowska J; Wietrzyk J
Pharmacol Rep; 2015 Aug; 67(4):711-8. PubMed ID: 26321272
[TBL] [Abstract][Full Text] [Related]
18. Src and focal adhesion kinase as therapeutic targets in cancer.
Brunton VG; Frame MC
Curr Opin Pharmacol; 2008 Aug; 8(4):427-32. PubMed ID: 18625340
[TBL] [Abstract][Full Text] [Related]
19. Tyrosine kinases as molecular targets to inhibit cancer progression and metastasis.
Cepero V; Sierra JR; Giordano S
Curr Pharm Des; 2010; 16(12):1396-409. PubMed ID: 20166985
[TBL] [Abstract][Full Text] [Related]
20. Current overview of angiogenesis inhibitors.
Ellis LM
Clin Adv Hematol Oncol; 2004 Aug; 2(8):494-6, 520. PubMed ID: 16163228
[No Abstract] [Full Text] [Related]
[Next] [New Search]
